Connect with us

Business News

Bristol-Myers gets $1.6 billion offer for French consumer health unit

Published

on

Loading...

[ad_1]

Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018. REUTERS/Regis Duvignau

Loading...

(Reuters) – Bristol-Myers Squibb Co (BMY.N) received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd (4581.T) to buy the company’s French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

The offer by Taisho is structured in the form of a “put option” agreement, the companies said.

Bristol-Myers said it estimates the potential deal would be approximately $0.04 dilutive to 2019 earnings.

Reporting by Rama Venkat in Bengaluru; Editing by Sunil Nair

[ad_2]

Loading...
Advertisement
Loading...
Loading...

Facebook

Loading...

Trending